Société Acumen Pharmaceuticals, Inc.
Actions
ABOS
US00509G2093
Recherche biotechnologique et médicale
Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
3,725 USD | -2,99 % | +0,41 % | -3,52 % |
Métier
Nombre d'employés: 52
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Daniel O'Connell
CEO | Chief Executive Officer | 54 | 01/04/06 |
Jim Doherty
PSD | President | 56 | 01/02 |
Matthew Zuga
DFI | Director of Finance/CFO | 58 | 01/05/21 |
Kasey Spencer
CTO | Chief Tech/Sci/R&D Officer | - | - |
Russell Barton
COO | Chief Operating Officer | 66 | 01/04/19 |
Eric Siemers
CTO | Chief Tech/Sci/R&D Officer | 68 | 01/06/18 |
Alexandria Braun
IRC | Investor Relations Contact | - | 01/09/22 |
Kathleen Pierce
PRN | Corporate Officer/Principal | - | - |
Amber Dilley
PRN | Corporate Officer/Principal | - | 01/01/21 |
Jasna Jerecic
PRN | Corporate Officer/Principal | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Daniel O'Connell
CEO | Chief Executive Officer | 54 | 01/04/06 |
Director/Board Member | 55 | 01/04/22 | |
Jeffrey Ives
BRD | Director/Board Member | 72 | 01/05/14 |
Sean Stalfort
BRD | Director/Board Member | 53 | 01/10/18 |
Derrell Porter
BRD | Director/Board Member | 53 | 04/01/23 |
Laura Stoppel
BRD | Director/Board Member | 38 | 01/11/20 |
Nathan Fountain
BRD | Director/Board Member | 61 | 01/06/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 60 079 778 | 53 329 161 ( 88,76 %) | 0 | 88,76 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-3,52 % | 231 M | |
+39,98 % | 54,04 Md | |
+43,57 % | 41,96 Md | |
-1,14 % | 41,92 Md | |
-7,59 % | 28,35 Md | |
+12,61 % | 26,35 Md | |
-22,10 % | 19 Md | |
+7,74 % | 13 Md | |
+28,18 % | 12,28 Md | |
+25,28 % | 12,19 Md |
- Bourse
- Actions
- Action ABOS
- Société Acumen Pharmaceuticals, Inc.